(NASDAQ: AGEN) Agenus's forecast annual revenue growth rate of -0.2% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Agenus's revenue in 2026 is $132,693,000.On average, 4 Wall Street analysts forecast AGEN's revenue for 2026 to be $6,371,738,203, with the lowest AGEN revenue forecast at $6,053,443,925, and the highest AGEN revenue forecast at $6,632,406,359. On average, 4 Wall Street analysts forecast AGEN's revenue for 2027 to be $6,295,653,715, with the lowest AGEN revenue forecast at $6,044,439,844, and the highest AGEN revenue forecast at $6,485,639,832.
In 2028, AGEN is forecast to generate $5,882,366,379 in revenue, with the lowest revenue forecast at $5,550,115,775 and the highest revenue forecast at $6,164,194,126.